Conferences  >  Medicine & Healthcare  >  Oncology

Mahatma Gandhi Medical College & Hospital Jaipur India

Phone: [00918004204751];     Email: vkkapoor.india@gmail.com

Biliary, gallbladder, liver, pancreas

Gastroenterology,    Surgery

ESMO - European Society for Medical Oncology

The ESMO Asia Congress is the annual event where global and Asian cancer professionals come together, to present and discuss the latest scientific and clinical advances across the entire field of oncology, of relevance at a global level, and for the Asia-Pacific region.

ESMO Registration Office;     Phone: [+41 (0)91 973 19 13];     Email: registration@esmo.org

Medical oncology, clinical oncology, surgical oncology, radiation oncology, oncology research, clinical practice guidelines, Pan-Asian Guidelines Adaptation

Translational Medicine, Clinical Trials,    Pharmacogenomics, Personalized Medicine

Precision Medicine Forum

This two-day forum brings together experts from across Europe and beyond to provide a truly unique environment for meaningful interactions with those at the very forefront of precision oncology. The multidisciplinary agenda will provide a platform for healthcare professionals, industry, patients groups, research, payers and Government to share their experiences and vision for a future of improved patient outcomes.

Email: amber@precisionmedicineforum.com

Topics will include: Developments with molecular analysis, Addressing inequality, diversity and inclusivity in care, access and treatment, Data harmonisation and interoperability, Profiling the future patient, Clinical implementation of precision oncology, Latest developments in liquid biopsy, and much more...

Baptist Health South Florida

The Miami Brain Symposium will focus on state-of-the-art approaches to the management of primary and metastatic central nervous systems tumors, along with an understanding of current standards of care and a look at future directions. This symposium will engage participants as the expert faculty navigate through complex cases, novel treatment strategies and lively panel discussions.

Phone: [13053215744];     Email: JulieZ@BaptistHealth.net

Neuro oncology CME, Neuro oncology conference, Brain Cancer conference, Brain Cancer Symposium

Binaytara Foundation

The 2023 Highlights of ASH is a CME-accredited, in-person hematology conference featuring leading experts in the field. This conference allows professionals an opportunity to discuss current research and advances in the field of blood disorders and hematologic malignancies with colleagues and key opinion leaders. Expert faculty will place key abstract findings from the 64th American Society of Hematology (ASH) Annual Meeting into clinical context and discuss how the results may change the current standard of care. The goals of this conference are to review and critically assess practice-changing results of practice-changing clinical data and expert recommendations to optimize clinical outcomes for the patients.

Event and Communication Assistant;     Phone: [4255575953];     Email: tiani.g@binayfoundation.org

Oncology, hematology, continuing education, medical conference, conference, CME

Hematology,    Continuing Medical Education (CME)

Binaytara Foundation

Management of breast cancer is rapidly evolving. A number of potentially practice-changing abstracts are expected to be presented during the 2022 San Antonio Breast Cancer Symposium (SABCS 2022) in December, 2022. At this in-person oncology conference held in Seattle, Highlights from SABCS 2022, expert faculty will place abstract findings from the SABCS 2022 annual meeting into clinical context and discuss how the results may change the current standard of care for breast cancer patients.

Event and Communication Assistant;     Phone: [4255575953];     Email: tiani.g@binayfoundation.org

oncology, breast cancer, women's health, medical conference, continuing education

Banff International Research Station (BIRS) for Mathematical Innovation and Discovery

In this workshop, we will discuss the current state of computational modelling in cancer biology and treatment. Through the exploration of in silico trials and ABMs, workshop participants will establish new, cutting-edge approaches in computational oncology, establishing new paradigms for understanding how cancer develops and how we can improve treatment outcomes in patients.

IASLC (International Association for the Study Lung Cancer)

Benefit from wide-ranging and multidisciplinary content including keynote lectures, round tables discussions, cancer control program and tobacco forum, oral abstract and poster presentations.

Depuis la découverte de la protéine PD-1 en 1992 par l’immunologiste Tasuku Honjo, c‘est tout un pan de l’immuno-oncologie qui s’est ouvert au monde de la recherche. Le bouleversement que l’arrivée des immunothérapie a entraîné a profondément modifié le quotidien de l’ensemble des acteurs de la filière de soin, des patients aux chercheurs, des praticiens aux anatomopathologistes, des laboratoires privés aux institutions de santé. L’essence même des Journées Scientifiques Immunité & Cancer (JSIC) est de réunir l’ensemble de la communité scientifique et médicale autour de cette thématique commune, pour participer à la diffusion et au partage des connaissances, ainsi qu’à l’émergence de nouveaux projets collaboratifs. L’objectif est d’offrir une opportunité unique aux différents acteurs de se rencontrer pour, in fine, améliorer la prise en charge de tous les patients atteints de cancer.

Binaytara Foundation

This CME-accredited activity “San Diego Multidisciplinary Thoracic Oncology Symposium: Patient-centered approach to improve outcomes” features leading experts in thoracic malignancies who will provide a comprehensive overview of current and emerging strategies for management of lung cancer (NSCLC, SCLC), mesothelioma, and thymic malignancies. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with thoracic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in molecular testing and targeted-therapies for thoracic oncology. Expert faculty will aim to place the role of different therapeutic agents in clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care.

Phone: [4255575953];     Email: meggan.m@binayfoundation.org

Lung Cancer, Cancer, CME, Conference, Oncology, Doctors, Medical

Quantitative Hallmarks of the Tumor Microenvironment

Cancer is a disease that affects individual molecules, cells, tissues, organs, and organisms in ways that promote disease. Ultimately, the dynamic interactions among these systems shape the forces that drive tumor initiation, progression, metastatic spread, and disease recurrence. The application of physics and mathematics foundations to the molecular, cellular, tissue, and organ level basis of cancer has revealed fundamental changes during disease that are reflected across cancer types and stages. In this conference we will hear from experts applying physical sciences to cancer to study disease phenomena across scales and systems.

Physical Oncology Across Biological Scales: Signals, Systems, Forces and Fluxes

DiaEdu

PAIRS 2023 will be once again the largest endovascular and interventional radiology conference in the region! No other Endovascular and Interventional Radiology meeting in the Middle East offers the diversity of topics, the range of learning environments, the unparalleled access to expert faculty and leading thinkers in the specialty than the PAIRS Congress. We are preparing a four-day comprehensive program that presents that presents high-level scientific content, live and recorded cases, poster presentations, interactive education and innovative discussions, cutting-edge technology and image-guided therapy providing both clinically relevant updates as well as hands-on educational activities

Phone: [0543457867];     Email: sara@diaedu.com

Interventional radiology conference, IR meeting, Middle East, radiology meeting, Embolization, Visceral Interventions, Abdominal and Pelvic Trauma, Visceral Interventions, Abdominal and Pelvic Trauma, Hepatobilay and GI, CLI, Venous Interventions, Oncology, PICC Line, Pedal and Radial Access, Carbon Dioxide CO2, Technologist Workshop, Particles, Gelfoam and Liquid Embolics, Coils and Plugs, Diabetic Foot, Varicose Veins, Aortic Interventions, Prostate Interventions, Acute Ischemic Stroke, Spine, Head and Neck, AVM and AVF, MSK, Intervention, Anuerysm

Deutsche Krebsgesellschaft Berlin, Deutsche Krebshilfe

The AEK Cancer Congress hosts around 500 participants. It is funded by the German Cancer Society and the German Cancer Aid and will be held in 2023 under the theme “Towards New Cancer Therapies: Mechanisms and Molecules”. You will see that we have assembled a great line-up of outstanding speakers, who will cover multiple exciting topics of current biology, from basic mechanism to new immunotherapies and the development of new therapeutic molecules.

Phone: [+49 364324680];     Email: katharina.pracht@kukm.de

Cancer, oncology, internal medicine, AEK, hematology

The European Association for Cancer Research (EACR)

The Mitogen Activated Protein Kinase (MAPK) pathway is among the most frequently mutated signalling cascade in human cancers. A multitude of small molecule inhibitors has been developed, allowing inhibited of upstream and downstream effectors of this pathway. Nevertheless, resistance is still a major issue. This conference will focus on basic and clinical aspects of the regulation of signaling through the MAPK pathway and its impact in cancer. A deep understanding of the mechanisms of intrinsic and adaptive resistance is essential for the more efficient agents. As the MAPK pathway also has implications for cross-resistance to immune checkpoint blockers, so targets and alternative combination therapies will also be discussed at the conference.

Binaytara Foundation

The 2023 Highlights of ASH is a CME-accredited, in-person hematology conference featuring leading experts in the field. This conference allows professionals an opportunity to discuss current research and advances in the field of blood disorders and hematologic malignancies with colleagues and key opinion leaders. Expert faculty will place key abstract findings from the 64th ASH Annual Meeting into clinical context and discuss how the results may change the current standard of care. The goals of this conference are to review and critically assess practice-changing results of practice-changing clinical data and expert recommendations to optimize clinical outcomes for the patients.

Event and Communication Assistant;     Phone: [4255575953];     Email: tiani.g@binayfoundation.org

oncology, hematology, continuing education, conference, binaytara foundation, event, CME

Continuing Medical Education (CME),    Hematology

European Society for Medical Oncology

ESMO TAT, known as “The Home of Phase I in Oncology”, is the leading congress focusing on promising new anticancer targets and agents, with a particular emphasis on those in early phase clinical development.

ESMO Registration Office;     Phone: [+41 (0) 91 973 19 13];     Email: registration@esmo.org

ESMO TAT, Targeted Anticancer Therapies Congress, TAT, European Society for Medical Oncology, Antibody-based therapies, Cell therapies, DNA damage repair, Epigenetics, Immunotherapy, Kinase-targeting agents and cell signalling modulators, Molecular profiling applications, cancer, oncology, clinical trials, anticancer targets and agents, cancer drugs

Translational Medicine, Clinical Trials,    Pharmacology and Drug Development

ESMO - European Society for Medical Oncology

ESMO Sarcoma & Rare Cancers is a new annual congress which will take place for the first time in Lugano, Switzerland, on 20 – 22 March 2023.

This highly specialised meeting will integrate contents from both the former ESMO Sarcoma GIST & Symposium and the ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers, bringing together the most brilliant medical minds working on these tumour types.

The ESMO Sarcoma & Rare Cancers Congress will constitute a unique occasion for the international rare cancers community to network and collaborate, featuring discussions with key opinion leaders in these sub-entities.

The congress will focus on the heterogeneous cohort of rare histologies across organ sites, and on their common themes: from diagnosis and pathology, to multidisciplinary expert management, from targeted therapies and precision medicine, to research, methodological challenges and policy.

ESMO Registration Office;     Phone: [+41 (0)91 973 19 13];     Email: registration@esmo.org

sarcoma, rare cancers

The European Association for Cancer Research (EACR)

This meeting will provide participants with a broad view of the scope, methodologies, future directions and challenges in addition to practical approaches for molecular pathology, focusing on comprehensive genomic profiling in cancer, in research and in clinical settings. We will discuss innovative approaches for empowering the next generation of molecular pathologists from practical and educational viewpoints. Upcoming applications of multiparametric immunoanalysis, liquid biopsy and artificial intelligence in pathology will be addressed. The meeting will help participants to establish a network of interactions and to build bridges to foster cross disciplinary studies. We are preparing for the future and for the unknown discoveries still to come.

Österreichische Gesellschaft für Hämatologie & Medizinische Onkologie

Das Vorprogramm mit einem vorläufigen Programmraster wird im Herbst 2022 veröffentlicht. Für die Frühjahrstagung werden DFP-Punkte für das Diplom-Fortbildungsprogramm der Österreichischen Ärztekammer beantragt.

OeGHO Akademie für Aus- und Fortbildung GmbH | Onconovum.academy;     Phone: [+43 1 934 62 67];     Email: academy@onconovum.at

Medicine (in general), Internal medicine,    Hematology

IDEOlogy Health

IDEOlogy Health has developed this educational meeting that will engage physicians and allied health professionals on the latest advances for the treatment of lung cancer. The goal of this activity is to provide a comprehensive update to medical oncologists and healthcare providers (academic and community) on the evolving treatments in thoracic oncology.

oncology, thoracic oncology, lung cancer, cancer, surgical oncology, immunotherapy, cme

The European Association for the Study of the Liver (EASL)

Fusion Conferences

This meeting will involve leaders in the field who study the biological basis of breast cancer, develop approaches for patient stratification, run clinical trials or develop new medicines for patients with breast cancer.

The European Association for Cancer Research (EACR)

Following the highly successful first, second and third editions, Defence is the Best Attack 2023 will be the fourth EACR conference on this topic. In this conference, we will learn about the most recent advances in the field of immunotherapy from the basic science to clinical studies including the identification of novel targets; an improved understanding of the mechanisms of action of therapeutic interventions; as well as discussions about biomarkers of response to treatment and mechanisms of intrinsic and acquired resistance to immunotherapy.

Deutsche Gesellschaft für Radioonkologie e. V.

Auf dem Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO) haben alle Fachkollegen/innen der DEGRO Gelegenheit, alle für die Entwicklung der Radioonkologie wichtigen Aspekte in konzentrierter Form zu diskutieren und: so zu einem breiten Erkenntnisaustausch zu kommen. Herausragende Forschungsleistungen werden auf diesem Kongress durch Wissenschaftspreise ausgezeichnet. An diesem Kongress sind auch die Angehörigen der in der Radioonkologie tätigen weiteren Berufsgruppen der MTRA (VMTRO), der Pflegenden in der Radioonkologie (BVPRO), der Medizinischen Fachangestellten in der Radioonkologie (MFAaBRO) und der Officeberufe (OVIRO) aktiv beteiligt.

Die Programmschwerpunkte des DEGRO-Kongress 2023 sind: Neue Technologien – neue Dosiskonzepte | High Tech – High Care: Der Patient im Mittelpunkt | Digitalisierung und Artificial Intelligence | Radio-Immuntherapie, Radio-Chemotherapie or what? | Arbeit im multiprofessionellen Team.

Kongressorganisation;     Phone: [+49 3643 2468-0];     Email: degro@kukm.de

Radioonkologie, Onkologie, Radiotherapie, Medizinphysik, Strahlenbiologie, Radioimmuntherapie, Radiochemotherapie, Digitalisierung, AI, Patientenzentrierung

Radiology, Nuclear Medicine and Radiation Therapy,    Translational Medicine, Clinical Trials

Translational Medicine, Clinical Trials,    Pharmacogenomics, Personalized Medicine

While animal modeling has been a staple of the cancer biology community for decades, it is only now maturing to its fullest potential. This conference will provide a forum for discussion on the past, present, and future of animal models for cancer, in particular the role that these models will play in the era of precision medicine.

Conventus Congressmanagement & Marketing GmbH

Email: conferencemarketing@conventus.de

Bio Ascend LLC

The International Workshop on Chronic Lymphocytic Leukemia (iwCLL) is a biennial meeting focused solely on advancing the understanding and treatment of chronic lymphocytic leukemia (CLL) and related lymphoproliferative disorders. Founded in 1979, iwCLL is now the largest international meeting dedicated to advancing state-of-the-art and emerging concepts—from laboratory-based research to the clinic—in the pathobiology and treatment of these blood cancers. The biennial meeting is intended to provide a forum that promotes the exchange of information and encourages collaboration among international leaders and scientists interested in CLL and lymphoproliferative disorders in one location for 4 days every other year.

Chronic lymphocytic Leukemia, ( CLL)

Continuing Medical Education (CME),    Hematology

The European Association for Cancer Research (EACR)

The EACR Goodbye Flat Biology conference returns in-person to focus on the next generation of cancer models and emerging topics in the areas of cell architecture, mechanobiology, the immune microenvironment, intravital imaging and high-content analysis for cancer therapeutics.

Conventus Congressmanagement & Marketing GmbH

Conventus Congressmanagement & GmbH;     Email: conferencemarketing@conventus.de